$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
News
News
Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
Is Quizartinib effective in myeloid leukemia? How effective is it in treating leukemia?
2026-02-01 22:25:32
Check Details
Where can tucatinib be purchased abroad? Overseas drug purchasing guide
2026-02-01 22:25:32
Check Details
What is the correct way to take Apelvis? Is it more appropriate to take it before or after meals?
2026-02-01 22:25:32
Check Details
Will resistance to selumetinib develop? Analysis of drug resistance mechanisms and coping strategies
2026-02-01 22:25:32
Check Details
What is the mechanism of action of the targeted therapy cabozantinib? How to choose the right patient group
2026-02-01 22:25:32
Check Details
What is the cure rate for bedaquiline? How effective is the cure for tuberculosis patients?
2026-02-01 22:25:32
Check Details
How to deal with the side effects of dasatinib? How to reduce the impact of side effects on patients?
2026-02-01 22:25:32
Check Details
Once used, does anamorelin need to be taken for life? Dosing cycles and discontinuation guidelines during treatment
2026-02-01 22:25:32
Check Details
Will alopecia areata relapse after treatment with baricitinib? How to evaluate recurrence rate and long-term efficacy
2026-02-01 22:25:32
Check Details
Contraindications for the use of ruxolitinib cream: Which groups are not suitable for use, and what matters need to be paid special attention to during use?
2026-02-01 22:25:32
Check Details
What are the side effects of Guanfacine?
2026-02-01 22:25:32
Check Details
What is the market price of giritinib in China? Drug Pricing and Purchasing Access
2026-02-01 22:25:32
Check Details
1
2
...
1479
1480
1481
1482
1483
1484
1485
...
10240
10241
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Ponatinib in the PACE Phase II Trial: Response Data in Resistant CML and Ph+ ALL
2
Selumetinib for NF1-Related Plexiform Neurofibromas: Time to Response and Response Assessment
3
How to Take Tucatinib (Tukysa): Dosing Schedule, Combination Use & Missed Dose Guidance
4
Ganaxolone Common Side Effects: Somnolence, Sedation and Safety Notes
5
Baxdrostat: Efficacy and Safety of a Novel Aldosterone Synthase Inhibitor
6
Anamorelin (ADLUMIZ): GHS-R1a Agonist for Cancer Cachexia—Mechanism, Use, and Safety Boundaries
7
Vemurafenib Mechanism and Clinical Indications: BRAF V600E Mutant Melanoma and ECD Treatment
8
Anagrelide Cautions and Contraindications: Allergy, Hepatic, Cardiac and Bleeding Risks
9
FDA Accelerated Approval of Voceryq: First Plasmid DNA Immunotherapy for Adult Recurrent Respiratory Papillomatosis
10
Ribociclib: Mechanism of Action and Approved Uses in Breast Cancer
11
Revumenib: Key Considerations Before and During Treatment
12
Pacritinib in Myelofibrosis: Evidence on Spleen Volume Reduction and Symptom Control